Insight has been given a sneak peak into the main exhibits featuring on the trade floor at the 2024 RANZCO Congress. Delegates can expect a host of product launches, updates and demonstrations, plus more.
See first-hand how Ellex laser devices are made
Lumibird Medical’s combined Ellex | Quantel Medical product portfolio offers a suite of advanced treatment solutions to drive greater value to ophthalmologist customers – much of which can be discovered at the congress.
On display will be the company’s range of multi-modality YAG lasers – including the latest Reflex Technology platforms spotlighting PROcap – and its retinal laser portfolio, providing some of the most advanced treatment solutions and covering a broad range of pathologies, the company says.
Furthermore, RANZCO delegates are exclusively invited to a ‘behind-the-scenes’ facility tour at the company’s Technolgy Park production site to see first-hand how Ellex’s world-class ophthalmic laser devices are manufactured 100% locally from the ground up.
“This opportunity is a unique insight behind Ellex, its rich history and manufacturing medical device processes,” the company says.
Registration is available via the RANZCO delegate registration website. Limited availability.
Booth: 25-28
The latest evolution of iStent MIGS
iStent technology has revolutionised the treatment of glaucoma in Australia and New Zealand since its introduction in 2016. Now, manufacturer Glaukos will showcase the latest innovation of its platform, iStent infinite.
As the smallest implantable device in the human body, the company says its technology has been a game-changer for patients diagnosed with glaucoma by effectively reducing eye pressure and medication burden – with more than one million successful implantations worldwide.
Approved by Australia’s TGA in 2024, the iStent infinite is designed to provide foundational, 24/7 therapy that gives ophthalmologists the power to deliver optimised treatment for patients with primary open angle glaucoma, currently treated with glaucoma medication including those who have failed prior medical or surgical intervention, while minimising the unwanted side effects of more invasive treatment options.
iStent infinite is also listed on the Prosthesis List. Glaukos can provide more information and a hands-on dry lab on its booth.
Booth: 101-102
Redefining Ophthalmic Day Surgeries
Ophthalmologists are being encouraged to visit the Vision Hospital Group (VHG) booth to understand how the day hospital group can provide a new edge to their surgical work.
VHG prides itself on offering cutting-edge operating suites and specialist theatre teams in a seamless, well-managed environment. With 11 day surgeries across New South Wales, Victoria, Queensland, and South Australia, the network is “uniquely positioned to deliver exceptional care and optimal patient outcomes”.
“Accommodating over 100 ophthalmologists who perform more than 33,500 procedures annually in our specialised facilities, excellence in eyecare is not just our aim – it’s our standard,” VHG says.
“If you’re an ophthalmologist seeking a day surgery with world-class patient satisfaction (as evidenced by our net promoter score), competitive fees, contracts with all major health funds, and flexible session options, visit our booth.”
Interested parties can also contact Ms Kylie Bennett, national director of nursing, at kylie.bennett@visionhospitalgroup.com.au or 0409 443 636.
Booth: 63
ZEISS debuting microscopes
In what is expected to be a busy four days on the ZEISS booth, the company is urging delegates to gain some hands-on experience with multiple product launches.
This includes the new ARTEVO 750 and ARTEVO 850 ophthalmic microscopes.
“Throughout the meeting you can join our short on-booth presentation sessionP s and hear directly from experts detailing their experiences with solutions from across the ZEISS Ecosystem,” the company says.
“Attendees can also join ZEISS on Sunday morning 3 November for a breakfast session where the focus will be placed on the diagnosis and treatment of retinal disease.
“The session will highlight the valuable role that ZEISS Retina Workplace plays in assessing retinal disease by bringing together multi-modality image.”
Booth: P4
Portable VR system to shine on BOC booth
BOC Instruments, a well established supplier and service provider for the national ophthalmc sector, will have a suite of reputable equipment on display at RANZCO.
The company’s range includes Frey slit lamps, retinal cameras, Optovue OCTs, hand-held autorefractors, chair & stands, innovative dry eye products and acuity charts, plus more.
“We shall be demonstrating an evolution in visual field testing with the VF2000 NEO virtual reality portable field tester with eye tracking,” the company says. “This innovative device provides unsurpassed accuracy and efficiency at exceptional value as also includes abundant additional vision testing features.”
According to BOC, the VF2000NEO is extremely compact, and can be used anywhere. It provides the same reliability as the “gold standard”. The device is supplied complete with a tablet PC, test reports can be uploaded up to the cloud and accessed remotely through the user’s unique portal.
Booth: 81-82
OptiMed showcasing Takagi tech
Industry supplier OptiMed is marking its return to the RANZCO Congress with an expansive range of specialist ophthalmic equipment.
This includes products from Japanese precision manufacturing powerhouse Takagi with its new operating microscope.
On display will also be F.I.S.O refraction stands, the latest in an expanding range of high-end ergonomic solutions, and EssilorLuxottica will also be displaying its groundbreaking liquid crystal refraction instruments.
Booth: 95-97
Optos devices take centre stage
Optos is encouraging ophthalmologists to discover the future of retinal imaging by visiting its stand where the California and Silverstone devices will be on show.
According to the company, the California device offers unparalleled ultra-widefield imaging, capturing up to 200° of the retina in a single image, ensuring comprehensive examinations and early detection of retinal conditions. Meanwhile, the Silverstone model goes a step further by integrating ultra-widefield imaging with OCT, providing both structural and functional insights into the retina.
“These innovative tools are essential for any practice committed to delivering the highest standard of eyecare,” Optos says.
“Don’t miss the opportunity to experience firsthand how Optos technology can enhance patient outcomes and elevate your practice.”
At the Optos booth, delegates can see the devices in action and speak with experts about how they can transform their approach to retinal imaging.
Booth: 67
Rayner and its suite of cataract surgery products
Rayner is a British company and the only manufacturer of intraocular lenses (IOLs) in the UK. The company also has a presence in Australia and New Zealand with a comprehensive range of IOLs, ophthalmic viscosurgical devices (OVDs), the Sophi phaco system and HASA single use instruments.
There’s also RayPRO which is a comprehensive patient reported outcome measurements (PROMs) platform that allows clinics to gain essential data on patient outcomes which can be used to inform their approach.
Rayner’s flagship IOL is the RayOne EMV and EMV Toric. It’s an extending range of vision IOL delivering up to 1.5 D of high-quality vision when used with an emmetropic target.
“The range of vision can be extended further with a customisable offset for enhanced monovision outcomes,” Rayner says.
“Developed in collaboration with Professor Graham Barrett, RayOne EMV’s truly non-diffractive optic utilises positive spherical aberration to uniquely extend vision whilst avoiding the problems that can arise with diffractive lenses.”
Booth: 59-60
New data reaffirms NovaTears’ strength
NovaTears will be a major focus of the AFT Pharmaceuticals stand at RANZCO 2024 off the back of the pivotal Phase 3 Gobi study reinforcing its effectiveness as a treatment for evaporative dry eye.
NovaTears was first approved in Australia in 2018, and the recent Gobi study laid the foundation for FDA approval in the US in May 2023 where it is marketed as MIEBO. From as early as two weeks, the therapy demonstrated statistically significant and clinically meaningful improvements in the signs and symptoms of dry eye disease associated with meibomian gland dysfunction.
In Australia and New Zealand, AFT also supplies NovaTears + Omega-3, a variation of the original NovaTears eye drop that contains concentrated, high quality Omega-3 of plant origin to provide enhanced lubrication and protection for dry and irritated eyes.
AFT has a significant presence in the preservative-free dry eye space, offering a range of options such as HYLO Forte, HYLO Fresh, and Opti-Soothe heat and eyelid wipes.
Booth: 64
CSL Seqirus marks RANZCO return
Pharmaceutical company CSL Seqirus is continuing its support of the RANZCO Congress where it will showcase its two products for dry eye disease.
“Our friendly and knowledgeable team will be there and are always more than happy to answer any questions you may have about Cationorm and Ikervis (ciclosporin 0.1%),” the company says.
“Cationorm sample packs will be available to healthcare professionals across the duration of the conference. We look forward to seeing you.”
Booth 11-14
B+L’s new standard-setting microscope
RANZCO will see the launch of Bausch + Lomb (B+L)’s new ophthalmic surgical microscope in Australia, SeeLuma.
The company says its fully digital surgical visualisation platform, equipped with 3D 55-inch and 31-inch monitors, promises to transform the way ophthalmic surgery is performed. The microscope, it says, is setting new standards in surgical precision while empowering ophthalmologists to deliver the best outcomes for their patients.
“The world’s first digital binoculars, intuitive user interfaces, and a design that allows surgeons to look straight at a heads-up monitor without having to twist their neck, make SeeLuma a game-changer in ophthalmic surgery,” B+L says.
With Mater Private Hospital Redland in Brisbane the first to have SeeLuma installed, congress delegates can see a demonstration of the microscope’s benefits on the B+L booth. They can also learn more at the B+L Symposium Breakfast on Saturday 2 November.
Meanwhile, B+L’s pharmaceutical business will have the Blink Dry Eye range on display too.
This includes blink Intensive Tears PLUS, which is a thicker, more viscous, advanced lubricating eye drop formulation that adapts to dry eye needs and provides long lasting relief. The drop has been specially formulated for enhanced ocular comfort, is recommended for both day and night use, contains hyaluronic acid, and is for moderate to severe dry eye.
Another product, blink Intensive Tears, will be a feature on the booth. B+L says this advanced lubricating eye drop is formulated to provide protection and comfort for eyes that are dry, irritated or uncomfortable.
It too contains hyaluronic acid and may be used with contact lenses.
Booth: 15-20
More reading
Your guide to the 2024 RANZCO Congress
Registrations rushing in for RANZCO Congress in Adelaide
Medical Training Survey 2023: RANZCO trainees working longer than peers
